HCC patients with high ACSL4 and low GADD45B expression have a much poorer overall and recurrence-free survival compared to patients with low ACSL4 and high GADD45B expression (Figures 6a and b). This evidence concerns the gene GADD45B and hepatocellular carcinoma.